PLA2G15 Antikörper (Center)
Kurzübersicht für PLA2G15 Antikörper (Center) (ABIN7842876)
Target
Alle PLA2G15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center
-
Verwendungszweck
- Rabbit polyclonal antibody to PLA2G15
-
Spezifität
- Recognizes endogenous levels of PLA2G15 protein
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the center region of human PLA2G15. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- PLA2G15 (Phospholipase A2, Group XV (PLA2G15))
-
Andere Bezeichnung
- PLA2G15
-
Hintergrund
- LYPLA3, Group XV phospholipase A2, 1-O-acylceramide synthase, ACS, LCAT-like lysophospholipase, LLPL, Lysophospholipase 3, Lysosomal phospholipase A2, LPLA2
-
Gen-ID
- 23659, 192654, 361401
-
UniProt
- Q8NCC3
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-